Tim J Kruser1, Wolfgang A Tome1, Songwon Seo2, John S Kuo1,3, Patrick A Turski4, Richard J Chappell2, Rufus A Scrimger5, Minesh P Mehta6. 1. Departments of Human Oncology. 2. Dept. of Biostatistics and Medical Informatics. 3. Dept. of Neurological Surgery. 4. Dept. of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. 5. Division of Radiation Oncology, University of Alberta, Edmonton, Alberta, Canada. 6. Department of Radiation Oncology, Northwestern Memorial Hospital, Chicago, Illinois, USA.
Abstract
OBJECTIVES: Few series analyzing prognostic fac tors predicting for obliteration of arteriovenous malformations (AVMs) following linear accelerator (LINAC)-based stereotactic radiosurgery (SRS) have been reported. We analyzed prognostic variables, outcomes, and toxicities in 88 patients undergoing LINAC-based SRS for AVMs. METHODS: Following IRB approval, patient records were retrospectively analyzed to identify independent predictors of complete response (obliteration) (CR) and time-to-CR. The majority of AVMs were treated using multiple isocenters and non-coplanar arcs. The median AVM volume was 2.67 cm3 (0.05 - 33.51). Median marginal and maximal doses were 17 (12-24) and 26.1 Gy (15-40), with a median prescription isodose surface of 65%. RESULTS: Spetzler-Martin (SM) grade was determined for 86 patients and was: I-3 pts (3%); II-23 pts (27%); III-45 pts (52%); IV-13 pts (15%); V-2 pts (2%).Of 80 patients with follow-up imaging, 44 (55%) had documented complete responses (CR). Kaplan-Meier estimate probability for CR at 4 years was 62% (95% CI: 0.50, 0.74). Median time to CR was 3 years (95% CI: 2.08, 3.17). Multivariate analysis demonstrated the Spetzler-Martin grade (OR=0.14 for grade III vs. grade I-II; p=0.004 and OR 0.07 for grade IV-V vs. grade I-II; p=0.002) and dichotomized marginal dose > 17 Gy (OR=4.19; p=0.01) to be significantly associated with CR. DISCUSSION: This report demonstrates that for LINAC-based SRS of AVM, marginal dose and Spetzler-Martin grade are strong predictors of complete AVM obliteration.
OBJECTIVES: Few series analyzing prognostic fac tors predicting for obliteration of arteriovenous malformations (AVMs) following linear accelerator (LINAC)-based stereotactic radiosurgery (SRS) have been reported. We analyzed prognostic variables, outcomes, and toxicities in 88 patients undergoing LINAC-based SRS for AVMs. METHODS: Following IRB approval, patient records were retrospectively analyzed to identify independent predictors of complete response (obliteration) (CR) and time-to-CR. The majority of AVMs were treated using multiple isocenters and non-coplanar arcs. The median AVM volume was 2.67 cm3 (0.05 - 33.51). Median marginal and maximal doses were 17 (12-24) and 26.1 Gy (15-40), with a median prescription isodose surface of 65%. RESULTS: Spetzler-Martin (SM) grade was determined for 86 patients and was: I-3 pts (3%); II-23 pts (27%); III-45 pts (52%); IV-13 pts (15%); V-2 pts (2%).Of 80 patients with follow-up imaging, 44 (55%) had documented complete responses (CR). Kaplan-Meier estimate probability for CR at 4 years was 62% (95% CI: 0.50, 0.74). Median time to CR was 3 years (95% CI: 2.08, 3.17). Multivariate analysis demonstrated the Spetzler-Martin grade (OR=0.14 for grade III vs. grade I-II; p=0.004 and OR 0.07 for grade IV-V vs. grade I-II; p=0.002) and dichotomized marginal dose > 17 Gy (OR=4.19; p=0.01) to be significantly associated with CR. DISCUSSION: This report demonstrates that for LINAC-based SRS of AVM, marginal dose and Spetzler-Martin grade are strong predictors of complete AVM obliteration.
Authors: C S Ogilvy; P E Stieg; I Awad; R D Brown; D Kondziolka; R Rosenwasser; W L Young; G Hademenos Journal: Circulation Date: 2001-05-29 Impact factor: 29.690
Authors: F Nataf; L Merienne; M Schlienger; D Lefkopoulos; J F Meder; E Touboul; J J Merland; B Devaux; B Turak; P Page; F X Roux Journal: Neurochirurgie Date: 2001-05 Impact factor: 1.553
Authors: M Schlienger; D Atlan; D Lefkopoulos; L Merienne; E Touboul; O Missir; F Nataf; H Mammar; K Platoni; P Grandjean; J N Foulquier; J Huart; C Oppenheim; J F Meder; E Houdart; J J Merland Journal: Int J Radiat Oncol Biol Phys Date: 2000-03-15 Impact factor: 7.038
Authors: D Petereit; M Mehta; P Turski; A Levin; C Strother; C Mistretta; R Mackie; M Gehring; S Kubsad; T Kinsella Journal: Int J Radiat Oncol Biol Phys Date: 1993-01-15 Impact factor: 7.038